HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Prohovnik, I. Articles by Alderson, P. O. Search for Related Content PubMed PubMed Citation Articles by Prohovnik, I. Articles by Alderson, P. O.

Cerebral perfusion as a diagnostic marker of early Alzheimer's disease

From the Departments of Psychiatry, Neurology, and Radiology, College of Physicians and Surgeons, Columbia University, and Brain Imaging Division, Department of Biological Psychiatry, New York State Psychiatric Institute, New York, NY.

Clinical diagnosis of Alzheimer's disease (AD) is not fully satisfactory, and laboratory markers of this disease are not yet established. We report substantial regional Cerebral Blood Flow (rCBF) abnormalities in patients with documented early stages of the disease, when differential diagnosis is most critical. Thirty-six patients with carefully documented clinical diagnosis of early AD (mean disease duration, 3.25 ± 1.80 years) and 12 elderly healthy controls participated in rCBF studies using the ¹³³Xe inhalation method. Whole-brain perfusion was significantly (p < 0.001) lower in the AD group, and a characteristic perfusion deficit was consistently found in temporoparietal cortex of the AD patients. Discriminant analyses demonstrated over 90% correct classification of the two groups. Two subgroups of patients with mildest disease manifestations were equally well discriminated. The similarity of these findings to those in late stages, which have been validated neuro-pathologically, offers indirect confirmation of validity and specificity. These results suggest that rCBF procedures may provide an accurate and sensitive laboratory marker for early AD.

Address correspondence and reprint requests to Dr. Prohovnik, Department of Biological Psychiatry, Psychiatric Institute, 722 West 168th Street, New York, NY 10032.

Supported in part by NIH grants AG 05433 and MH 35636, and grants from the Jean and Louis Dreyfus Foundation and the Charles S. Robertson Memorial Gift for research in Alzheimer's disease.

Received September 3, 1987. Accepted for publication in final form October 28, 1987.

This article has been cited by other articles:

				V. Fodale, D. Quattrone, C. Trecroci, V. Caminiti, and L. B. Santamaria Alzheimer's disease and anaesthesia: implications for the central cholinergic system Br. J. Anaesth., October 1, 2006; 97(4): 445 - 452. [Abstract] [Full Text] [PDF]

				L. Park, J. Anrather, P. Zhou, K. Frys, R. Pitstick, S. Younkin, G. A. Carlson, and C. Iadecola NADPH Oxidase-Derived Reactive Oxygen Species Mediate the Cerebrovascular Dysfunction Induced by the Amyloid {beta} Peptide J. Neurosci., February 16, 2005; 25(7): 1769 - 1777. [Abstract] [Full Text] [PDF]

				L Mosconi, K Herholz, I Prohovnik, B Nacmias, M T R De Cristofaro, M Fayyaz, L Bracco, S Sorbi, and A Pupi Metabolic interaction between ApoE genotype and onset age in Alzheimer's disease: implications for brain reserve J. Neurol. Neurosurg. Psychiatry, January 1, 2005; 76(1): 15 - 23. [Abstract] [Full Text] [PDF]

				B. A. Fallon, J. Keilp, I. Prohovnik, R. V. Heertum, and J. J. Mann Regional Cerebral Blood Flow and Cognitive Deficits in Chronic Lyme Disease J Neuropsychiatry Clin Neurosci, August 1, 2003; 15(3): 326 - 332. [Abstract] [Full Text] [PDF]

				O.-C. Suter, T. Sunthorn, R. Kraftsik, J. Straubel, P. Darekar, K. Khalili, and J. Miklossy Cerebral Hypoperfusion Generates Cortical Watershed Microinfarcts in Alzheimer Disease Stroke, August 1, 2002; 33(8): 1986 - 1992. [Abstract] [Full Text] [PDF]